Tributyrin for mild Alzheimer's: a gut-brain study
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a supplement called tributyrin, which may help people with mild Alzheimer's by affecting the gut-brain connection. It aims to see if raising butyrate levels in the body can improve memory and thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild Alzheimer's disease within the past year.
- You do not have other conditions that could cause dementia, like a severe head injury, brain tumor, or epilepsy.
- You are not currently taking medications that could interfere, such as steroids, antibiotics, or chemotherapy in the past month.
- You do not have any gastrointestinal disorders like Crohn's disease or chronic bowel problems.
- You are not participating in any other clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a supplement called genistein can help people with mild memory problems caused by early Alzheimer's disease. You must have a brain scan showing amyloid buildup and be otherwise healthy enough to participate.
This trial tests a supplement called tributyrin to see if it can help with thinking and memory problems in people with Parkinson's disease. You may be able to join if you have both Parkinson's and mild cognitive impairment or dementia.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.
This study tests an experimental oral medication called Gut-X-001 that may help slow thinking and memory problems in people with Alzheimer's disease by working through the gut. You'll take the medication for several months while doctors monitor your cognitive health and safety.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.